139 related articles for article (PubMed ID: 506622)
1. The significance of renin and angiotensin in renovascular hypertension in man.
Fagard R; Amery A; Billiet L; Joossens JV; Lijnen P; Reybrouck T
Acta Clin Belg; 1979; 34(3):130-9. PubMed ID: 506622
[No Abstract] [Full Text] [Related]
2. Effects of 1-Sar-8-Ala-angiotensin II on systemic and pulmonary haemodynamics in hypertensive patients.
Fagard R; Amery A; Lijnen P; Reybrouck T; Joossens JV; Billiet L; Moerman E; De Schaepdryver A
Clin Exp Pharmacol Physiol; 1978; 5(5):457-64. PubMed ID: 729204
[No Abstract] [Full Text] [Related]
3. [Hemodynamic effects of sar1-ala8-angiotensin in patients with renovascular hypertension (author's transl)].
Philipp T; Zschierdrich H; Distler A
Klin Wochenschr; 1977 Sep; 55(18):917-9. PubMed ID: 916618
[TBL] [Abstract][Full Text] [Related]
4. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
[No Abstract] [Full Text] [Related]
5. Detection of renovascular hypertension: saralasin test versus renin determinations.
Marks LS; Maxwell MH; Smith RB; Cahill PJ; Kaufman JJ
J Urol; 1976 Oct; 116(4):406-9. PubMed ID: 1053323
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension.
Gavras H; Flessas A; Ryan TJ; Brunner HR; Faxon DP; Gavras I
JAMA; 1977 Aug; 238(8):880-2. PubMed ID: 577978
[TBL] [Abstract][Full Text] [Related]
7. Effect of saralasin on plasma aldosterone in hypertensive man.
Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
[No Abstract] [Full Text] [Related]
8. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
Helber A; Hummerich W; Bönner G; Meurer KA; Moritz G
Verh Dtsch Ges Kreislaufforsch; 1977; 43():208-9. PubMed ID: 613575
[No Abstract] [Full Text] [Related]
9. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
Beckerhoff R; Vetter W; Furrer J; Nussberger J; Schmied U; Siegenthaler W
Dtsch Med Wochenschr; 1976 Mar; 101(11):398-401. PubMed ID: 1253700
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute hemodialysis-induced changes in sodium balance on the renin-angiotensin system in renovascular and spontaneously hypertensive rats.
Röckel A; Brand A; Bechinger W; Heidland A
Res Exp Med (Berl); 1979 Oct; 176(1):7-14. PubMed ID: 523796
[TBL] [Abstract][Full Text] [Related]
11. [Hemodynamic changes after angiotensin II blockade by saralasin (author's transl)].
Liebau G; Beyer J; Larbig D; Schick K; Sekanina G; Hayduk K
Klin Wochenschr; 1977 Jul; 55(13):647-9. PubMed ID: 19645
[TBL] [Abstract][Full Text] [Related]
12. Detection of renovascular hypertension with angiotensin II blockade.
Baer L; Parra-Carrilo JZ; Radichevich I; Williams GS
Ann Intern Med; 1977 Mar; 86(3):257-60. PubMed ID: 842983
[TBL] [Abstract][Full Text] [Related]
13. Response to saralasin and angiotensin's role in essential and renal hypertension.
Hollenberg NK; Williams GH; Adams DF; Moore T; Brown C; Borucki LJ; Leung F; Bavli S; Solomon HS; Passan D; Dluhy R
Medicine (Baltimore); 1979 Mar; 58(2):115-27. PubMed ID: 431398
[No Abstract] [Full Text] [Related]
14. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
[TBL] [Abstract][Full Text] [Related]
15. Effect of sodium depletion and angiotensin II antagonism in renal hypertensive rabbits.
Johnson JA; Stubbs DH; Stanton M; Payne C; Ichikawa S; Keitzer WF
Am J Physiol; 1977 Oct; 233(4):H514-9. PubMed ID: 910968
[No Abstract] [Full Text] [Related]
16. [Saralasin and prediction of the surgical result in renovascular arterial hypertension].
Mimran A; Deschodt G; Fourcade J; Barjon P
Arch Mal Coeur Vaiss; 1979 Nov; 72 Spec no():16-21. PubMed ID: 119507
[TBL] [Abstract][Full Text] [Related]
17. Role of renin-angiotensin system in experimental hypertension in rats: plasma renin and hypotensive effect of angiotensin II antagonist.
Yamamoto J
Jpn Circ J; 1977 Jun; 41(6):665-75. PubMed ID: 886656
[No Abstract] [Full Text] [Related]
18. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
Fagard R; Amery A; Ljnen P; Reybrouck T; Billiet L
Prog Biochem Pharmacol; 1976; 12():242-9. PubMed ID: 1019167
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
[TBL] [Abstract][Full Text] [Related]
20. Renin, blood volume and response to saralasin in patients on chronic haemodialysis: evidence against volume- and renin-'dependent' hypertension.
McGrath BP; Ledingham JG
Clin Sci Mol Med; 1978 Mar; 54(3):305-12. PubMed ID: 630806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
